Kidney Cancer JAVELIN 101: Toni Choueiri, MD | Dana-Farber Cancer Institute [Video]

Kidney cancer research at ASCO24: Final analysis in JAVELIN Renal 101 trial confirms the efficacy and manageable safety profile of avelumab plus axitinib versus sunitinib in patients with advanced kidney cancer. Dana-Farber’s Toni Choueiri, MD, explains more. Video published 6/7/2024